Paediatric Endocrinology
Clinical research focused on growth disorders in children and adolescents, with attention to conditions affecting stature, growth pattern, and developmental height outcomes.
- Idiopathic short stature
- Short stature homeobox-containing gene deficiency
- Small for gestational age
- Turner syndrome
Trial activity centres on therapeutic approaches used in growth hormone-related care for paediatric patients with short stature and growth failure.
Growth Hormone Therapies
Research interest includes medical treatments for growth hormone sufficient disorders and other causes of impaired linear growth in young patients.
- Somatropin
- Lonapegsomatropin
- Weekly growth hormone treatment
- Height velocity
The sponsor’s clinical focus includes therapies relevant to pediatric height management and endocrine conditions associated with reduced growth.
Genetic and Syndromic Growth Disorders
Studies extend to inherited and syndromic conditions where genetic factors contribute to short stature and altered physical development.
- SHOX deficiency
- Turner syndrome
- Hereditary short stature
This area reflects interest in therapies used for children with chromosomal or gene-related growth impairment.
International Paediatric Trial Network
Clinical activity spans multiple countries and research sites, supporting studies in children’s endocrinology across diverse clinical settings.
- Collaborating research sites
- Multinational recruitment
- Paediatric patient access
The sponsor’s research footprint includes centres involved in endocrine treatment evaluation for growth-related conditions.
